Your browser doesn't support javascript.
loading
Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
Attarbaschi, Andishe; Mann, Georg; Zimmermann, Martin; Bader, Peter; Barisone, Elena; Basso, Giuseppe; Biondi, Andrea; Cario, Gunnar; Cazzaniga, Gianni; Colombini, Antonella; Flotho, Christian; Kuhlen, Michaela; Lang, Peter; Lauten, Melchior; Linderkamp, Christin; Locatelli, Franco; Lo Nigro, Luca; Möricke, Anja; Niggli, Felix; Panzer-Grümayer, Renate; Parasole, Rosanna; Peters, Christina; Caterina Putti, Maria; Rizzari, Carmelo; Suttorp, Meinolf; Valsecchi, Maria Grazia; Conter, Valentino; Schrappe, Martin.
Afiliação
  • Attarbaschi A; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria. andishe.attarbaschi@stanna.at.
  • Mann G; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical School Hannover, Hannover, Germany.
  • Bader P; Department of Children and Adolescent Medicine, Children's Hospital, Goethe University, Frankfurt, Germany.
  • Barisone E; Pediatric Onco-Hematology, Regina Margherita Children's Hospital, AOU Città della Salute e della Scienza, Turin, Italy.
  • Basso G; Italian Institute for Genomic Medicine, Turin, Italy.
  • Biondi A; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
  • Cario G; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Cazzaniga G; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
  • Colombini A; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
  • Flotho C; Department of Pediatric Hematology and Oncology, Children's Hospital, Albert Ludwigs University, Freiburg, Germany.
  • Kuhlen M; University Children's Hospital Augsburg, Swabian Children's Cancer Center, Augsburg, Germany.
  • Lang P; Department of Pediatric Hematology and Oncology, Children's Hospital, Eberhard Karls University, Tübingen, Germany.
  • Lauten M; Department of Pediatric and Adolescent Medicine, Children's Hospital, University of Lübeck, Lübeck, Germany.
  • Linderkamp C; Department of Pediatric Hematology and Oncology, Children's Hospital, Medical School Hannover, Hannover, Germany.
  • Locatelli F; Department of Pediatric Hematology-Oncology, IRCCS "Bambino Gesù" Children's Hospital, Rome, Italy.
  • Lo Nigro L; Department of Pediatrics, Sapienza, University of Rome, Rome, Italy.
  • Möricke A; Center of Pediatric Hematology Oncology, Azienda Policlinico-OVE, Catania, Italy.
  • Niggli F; Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Panzer-Grümayer R; Department of Pediatric Oncology, University Children's Hospital, Zürich, Switzerland.
  • Parasole R; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Peters C; Department of Pediatric Hemato-Oncology, A.O.R.N. Santobono-Pausilipon, Naples, Italy.
  • Caterina Putti M; Department of Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
  • Rizzari C; Department of Woman and Child Health, Clinic of Pediatric Haematology-Oncology, University of Padova, Padova, Italy.
  • Suttorp M; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
  • Valsecchi MG; Department of Pediatrics, Pediatric Hemato-Oncology Unit, Children's Hospital, University Hospital "Carl Gustav Carus", Dresden, Germany.
  • Conter V; Center of Biostatistics for Clinical Epidemiology, Department of Health Science, University of Milano-Bicocca, Milano, Italy.
  • Schrappe M; Pediatric Hematology-Oncology Unit, Department of Pediatrics, University of Milano-Bicocca, MBBM Foundation/ASST Monza, Monza, Italy.
Leukemia ; 34(6): 1694-1700, 2020 06.
Article em En | MEDLINE | ID: mdl-31806872

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Leukemia Ano de publicação: 2020 Tipo de documento: Article